Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM

NCT05594797 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Human BCMA Targeted T Cells Injection

Sponsor

Hrain Biotechnology Co., Ltd.

Collaborators

[object Object]
[object Object]